| Dr Joseph Sun, MD | |
|
234 Goodman St, Cincinnati, OH 45219-2364 | |
| (513) 475-8282 | |
| Not Available |
| Full Name | Dr Joseph Sun |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 9 Years |
| Location | 234 Goodman St, Cincinnati, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083001127 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Cincinnati Medical Center, Llc | Cincinnati, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Cincinnati Physicians Company Llc | 2264344480 | 1339 |
News Archive
The Eighth Annual Chronic Total Occlusion Summit and Left Main Coronary Interventions Course is a three-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions and left main coronary interventions.
One classical question in developmental biology is how different tissue types arise in the correct position of the developing embryo. While one signaling pathway that controls this process has been well described, unexpected findings from a team led by Carnegie's Steven Farber reveal the importance of polyunsaturated fatty acid metabolism in this process. It is published online December 12 in Developmental Cell.
A chemical compound found normally in the blood has shown promise in treating and preventing an intractable form of heart failure in a mouse model of the disease, report researchers at the University of Illinois at Chicago College of Medicine.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the first quarter ended March 31, 2012.
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that an abstract reporting new data from the BiovaxID Phase II mantle cell lymphoma clinical trial conducted by the U.S. National Cancer Institute (NCI) is now available on-line with the significance of these results to be presented by the NCI at the 2012 American Society of Clinical Oncology Annual Meeting.
› Verified 5 days ago
| Entity Name | University Of Cincinnati Physicians Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801840434 PECOS PAC ID: 2264344480 Enrollment ID: O20031105000123 |
News Archive
The Eighth Annual Chronic Total Occlusion Summit and Left Main Coronary Interventions Course is a three-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions and left main coronary interventions.
One classical question in developmental biology is how different tissue types arise in the correct position of the developing embryo. While one signaling pathway that controls this process has been well described, unexpected findings from a team led by Carnegie's Steven Farber reveal the importance of polyunsaturated fatty acid metabolism in this process. It is published online December 12 in Developmental Cell.
A chemical compound found normally in the blood has shown promise in treating and preventing an intractable form of heart failure in a mouse model of the disease, report researchers at the University of Illinois at Chicago College of Medicine.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the first quarter ended March 31, 2012.
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that an abstract reporting new data from the BiovaxID Phase II mantle cell lymphoma clinical trial conducted by the U.S. National Cancer Institute (NCI) is now available on-line with the significance of these results to be presented by the NCI at the 2012 American Society of Clinical Oncology Annual Meeting.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Sun, MD 231 Albert Sabin Way Po Box 670531, Cincinnati, OH 45267-0531 Ph: (513) 558-2402 | Dr Joseph Sun, MD 234 Goodman St, Cincinnati, OH 45219-2364 Ph: (513) 475-8282 |
News Archive
The Eighth Annual Chronic Total Occlusion Summit and Left Main Coronary Interventions Course is a three-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions and left main coronary interventions.
One classical question in developmental biology is how different tissue types arise in the correct position of the developing embryo. While one signaling pathway that controls this process has been well described, unexpected findings from a team led by Carnegie's Steven Farber reveal the importance of polyunsaturated fatty acid metabolism in this process. It is published online December 12 in Developmental Cell.
A chemical compound found normally in the blood has shown promise in treating and preventing an intractable form of heart failure in a mouse model of the disease, report researchers at the University of Illinois at Chicago College of Medicine.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the first quarter ended March 31, 2012.
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that an abstract reporting new data from the BiovaxID Phase II mantle cell lymphoma clinical trial conducted by the U.S. National Cancer Institute (NCI) is now available on-line with the significance of these results to be presented by the NCI at the 2012 American Society of Clinical Oncology Annual Meeting.
› Verified 5 days ago
Alexander Topala, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 234 Goodman St, Mail Location 0796, Cincinnati, OH 45219 Phone: 513-584-1000 | |
Eli Cianciolo, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4805 Montgomery Rd, Suite 210, Cincinnati, OH 45212 Phone: 513-791-6400 Fax: 513-791-5306 | |
Angel Joshua Pagan, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 234 Goodman St, Cincinnati, OH 45219 Phone: 513-558-6356 | |
Dave Wright, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2139 Auburn Ave, Cincinnati, OH 45219 Phone: 513-585-2422 Fax: 513-585-3245 | |
Robert S Jacob, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2139 Auburn Ave, Cincinnati, OH 45219 Phone: 513-672-3309 Fax: 513-672-3323 | |
Mr. Kun Lee, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4777 E Galbraith Rd, Cincinnati, OH 45236 Phone: 513-686-3000 | |
Nalini Tandon, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 7500 State Rd, Anethesia Intensive Care Consultants Inc, Cincinnati, OH 45255 Phone: 859-341-7246 Fax: 859-341-7867 |